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Introduction: Haemophilus pittmaniae was described in 2005 as a new species distantly related to Haemophilus
parainfluenzae. This member of the human saliva microbiota has also been further isolated from various body fluids
without formal description of the patients.
Case presentation: We report the case of H. pittmaniae isolate made from a sputum specimen collected from a
58-year-old Caucasian man with a massive fibrotic form of siderosis who was awaiting lung transplantation.
Identification of the isolate was ascertained by matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry and 16S rRNA gene sequencing. H. pittmaniae was considered to be responsible for the worsening of
the patient’s chronic respiratory failure and was successfully treated with oral amoxicillin.
Conclusion: H. pittmaniae should be regarded as a new pathogen responsible for respiratory tract infection in
patients with chronic lung diseases.Introduction
Haemophilus pittmaniae has recently been delineated as
a new member within the genus Haemophilus after multi-
locus sequence analysis of nine human isolates collected
from six different clinical sources [1]. This organism
has been determined as being part of the normal oral
microbiota of humans [1]. Phylogenetic and phenotypic
studies have shown that H. pittmaniae belongs to the
phylum Proteobacteria within the family Pasteurellaceae,
Haemophilus parainfluenzae cluster. In our present report
on H. pittmaniae, we found no previous clinical descrip-
tion of patients with this entity, hence hampering the
interpretation of isolation of this organism in clinical spe-
cimens. We report the case of a patient which provides
evidence for H. pittmaniae as an organism involved in
respiratory tract infection.
Case presentation
A 58-year-old Caucasian man was admitted to the
Department of Pulmonary Disease at our institution for
worsened chronic respiratory failure. He had an end-stage* Correspondence: Michel.Drancourt@univmed.fr
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reproduction in any medium, provided the orfibrotic form of siderosis and had been evaluated 3 months
earlier as candidate for lung transplantation. At admission,
the patient presented with fever at 38.5°C, cough with mild
productive sputum, an important increased dyspnea
on exertion and severe hypoxemia requiring oxygen
supplementation of 12L/minute at rest to obtain a sys-
temic oxygen saturation of 94%, whereas he had required
6L/minute at rest 3 months before this presentation. His
peripheral white blood cell count was 15.2 g/L, and neu-
trophils were 10.6g/L. There was no other organ dysfunc-
tion. A chest X-ray (CXR) and computed tomographic
(CT) scan were obtained on admission. The radiological
findings confirmed a pattern of advanced fibrosis. There
were no significant changes or new findings compared to
the CXR and CT scan obtained 3 months previously.
He had stopped smoking 5 months before his current
presentation, and his body mass index was 29.4kg/m2.
His usual treatment consisted of nebulized terbutaline
5mg and ipratropium bromide 0.5mg, three times daily,
together with oral prednisone 40mg/day tapered to
30mg/day during this hospitalization. In this context, an
expectorated sputum specimen was collected for micro-
biological investigations. H. pittmaniae was isolated in this
specimen. Other causes of respiratory decompensation
were excluded, and his respiratory virus panel and fungil Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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single antibiotic, oral amoxicillin 3g/day, was administered
for 10 days, which had a rapid clinical benefit, permitting
his oxygen supplementation to be reduced to the previous
dosage of 6L/minute at rest and allowing him to await
the single-lung transplantation, which was performed
successfully 2 months later.
Direct microscopic examination of the sputum speci-
men showed the presence of numerous polymorpho-
nuclear leukocytes and a few epithelial cells, but no
bacteria were detected after Gram staining. The sputum
specimen was cultured on chocolate agar (BioMérieux,
Marcy l’Etoile, France), incubated under a 5% CO2-
enriched atmosphere at 37°C and on Columbia agar
(BioMérieux) under aerobic and anaerobic atmospheres
at 37°C. Antibiotic susceptibility testing was performed
by determining the minimum inhibitory concentration
to amoxicillin, amoxicillin-clavulanate, ceftriaxone, gen-
tamicin, ciprofloxacin, erythromycin and doxycycline
using the disk diffusion method on a chocolate agar
(BioMérieux) incubated under a 5% CO2-enriched atmos-
phere at 37°C and read after 48-hour incubation. The
presence of β-lactamase was tested by using the cefinase
test with a paper disk impregnated with nitrocefin (Becton
Dickinson, Le Pont de Claix, France) in the presence of a
β-lactamase-producing H. influenzae isolate as a positive
control.
The chocolate agar showed grayish white colonies
after 48-hour incubation in aerobic atmosphere, whereas
the Columbia agar plates remained sterile after 5-day
incubation in both aerobic and anaerobic atmospheres.
Gram staining revealed Gram-negative bacilli susceptible
to β-lactam and ciprofloxacin (Table 1). The cefinase test
was negative.
One colony was harvested and deposited on MTP 384
target plate polished steel (Brüker Daltonik GmbH,
Bremen, Germany) in four replicates. Two microliters of
matrix solution (saturated α-cyano-4-hydroxycinnamic
acid, 50% acetonitrile and 2.5% trifluoroacetic acid) were
then added, and samples were air-dried for 5 minutesTable 1 Antibiotic susceptibility pattern of a Haemophilus









Doxycycline 8before being processed in the mass spectrometer.
Measurements were performed using an autoflex II
matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass spectrometer (Brüker Daltonik
GmbH). Four raw spectra were automatically acquired
using Brüker Daltonik’s flexControl version 3.0 software
and then compared with the Brüker Daltonik database and
MALDI Biotyper version 2.0 software (Brüker Daltonik
GmbH). To validate the analysis of a whole MTP 384
target, bacterial test standard (protein extract of Escherichia
coli DH5α, 255343; Brüker Daltonik GmbH) and matrix
solution were added to the analysis batch as positive and
negative controls, respectively. Two deposits of 1.5 μl of
bacterial test standard covered with 1.5 μl of matrix were
used to calibrate the Brüker Daltonik Biotyper analysis and
as a validation standard for the analysis. To validate the
analysis using the Maldi Biotyper software, the bacterial
identification must be E. coli with an identification score >2
and the two negative controls’ deposits of 1.5 μl of matrix
solution must give a score <1.7. In MALDI-TOF mass
spectrometric analysis, negative controls yielded faint spec-
tra with non-significant identification scores and the E. coli
positive control yielded the expected spectrum. The isolate
yielded four spectra (Figure 1), and the comparison
with the Brüker Daltonik database yielded identifica-
tion of H. pittmaniae three times, with scores of
2.085, 2.062 and 2.081. The fourth colony was identi-
fied as H. parainfluenzae, with a score of 2.014.
Bacterial DNA was extracted by using a MagNA
Pure LC DNA Isolation Kit III (Roche Diagnostics,
Meylan, France) with a MagNA Pure LC instrument
according to the manufacturer’s instructions. Polymerase
chain reaction (PCR) amplification of the 16S rRNA gene
was performed by using the universal primer pair fD1 (5′-
AGAGTTTGATCCTGGCTCAG-3′) and rP2 (5′-
ACGGCTACCTTGTTACGACTT-3′) [2,3] in an ABI
2720 thermal cycler (Applied Biosystems, Courtaboeuf,
France). PCR mix without DNA was used as a negative
control. PCR products were purified by using a Multi-
Screen PCR filter plate (Millipore, Molsheim, France),
and sequencing reactions were carried out by using a
DNA sequencing kit (BigDye Terminator Cycle Sequen-
cing Ready Reaction Kit version 1.1; Applied Biosystems)
according to the manufacturer’s instructions. Sequencing
products were purified and electrophoresis was performed
with a 3130 Genetic Analyzer (Applied Biosystems).
Sequences obtained were analyzed with AutoAssem-
bler software (Applied Biosystems) and Sequencher
software (Gene Codes Corp, Ann Arbor, MI, USA)
and compared with those available in the GenBank
database by using the BLAST program (http://blast.
ncbi.nlm.nih.gov/Blast.cgi). PCR yielded a unique
product, but negative controls remained negative. The
1464-bp 16S rRNA gene sequence was compared with
Figure 1 Brüker Daltonics flexAnalysis of H. pittmaniae (upper panel) and H. parainfluenzae (lower panel) MALDI-TOF mass
spectrometry protein spectra. X axis, m/z value of peaks; y axis, relative intensity of peaks.
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found to be 99% similar to that of H. pittmaniae (NR
025423.1, strain HK85). The next closest bacteria was H.
parainfluenzae with a 97% similarity score.
Discussion
In our present case report, we describe the first H.
pittmaniae isolate found in our laboratory, suggesting
that this isolate did not result merely from contamin-
ation but was indeed present in the sputum specimen,
despite the fact that it was not detected by direct
microscopic examination. The isolate was taken from a
specimen collected from a patient at the time of wor-
sening chronic respiratory failure. Accordingly, the
patient’s condition rapidly improved when he was
started on amoxicillin, an antibiotic therapy guided by
the in vitro susceptibility pattern of the H. pittmaniae
isolate. These data suggest that this H. pittmaniae
strain may have played a role in our patient’s worsening
respiratory function, along with a potential facilitating
role of infection by maintenance therapy with steroids.
Indeed, the only previous report of this new organism
lacked any clinical detail that would have allowed the
interpretation of this rarely encountered bacterium.
Nevertheless, that initial description of H. pittmaniae
reported this new species as an opportunistic pathogenisolated from blood and bile in humans. The data
reported herein suggest the respiratory tract as an add-
itional site of opportunistic H. pittmaniae infection
[3].
In this case report, the accurate identification of the
isolate was ensured by both MALDI-TOF mass spec-
trometry and 16S RNA gene sequencing after H. pitt-
maniae was identified on the basis of multilocus
sequence analysis [1]. Whereas this labor- and time-
intensive method cannot be used for the routine iden-
tification of Haemophilus spp. isolates, MALDI-TOF
mass spectrometry proved to be the most rapid and
cost-effective tool for identification, as previously
reported for bacteria in general [5]. We previously
observed that accurate MALDI-TOF mass spectrometry-
based identification of bacteria required a minimum of 10
reference spectra in the database [5]. In our present case,
despite the fact that the Bruker Daltonik database
included only one H. pittmaniae reference spectrum, we
obtained three of four spectra corresponding to this iden-
tification, whereas one of the four spectra gave a H. para-
influenzae identification with a lower score. These two
bacteria have close, albeit distinct, spectra (Figure 1),
which is in agreement with their taxonomic relationships
as assessed by 96.7% similarity in the sodA sequence
[5]. 16S rRNA gene sequence analysis previously revealed
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related to the “Haemophilus sensu stricto” group [1,4].
Conclusion
H. pittmaniae is a rare opportunistic pathogen which
can worsen chronic respiratory failure. MALDI-TOF mass
spectrometry is a first-line method for identification
of H. pittmaniae isolates. This case report helps in the
interpretation of H. pittmaniae as an opportunistic patho-
gen requiring appropriate antibiotic treatment to improve
the patient’s health status.
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